A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood

Edward A. Wintner, Thomas L. Deckwerth, William Langston, Asa Bengtsson, Dina Leviten, Paul Hill, Michael A. Insko, Ronald Dumpit, Emily Vandenekart, Christopher F. Toombs, Csaba Szabo

Research output: Contribution to journalArticle

145 Citations (Scopus)

Abstract

Background and purpose: Hydrogen sulphide (H2S) is a labile, endogenous metabolite of cysteine, with multiple biological roles. The development of sulphide-based therapies for human diseases will benefit from a reliable method of quantifying H2S in blood and tissues. Experimental approach: Concentrations of reactive sulphide in saline and freshly drawn whole blood were quantified by reaction with the thio-specific derivatization agent monobromobimane, followed by reversed-phase fluorescence HPLC and/or mass spectrometry. In pharmacokinetic studies, male rats were exposed either to intravenous infusions of sodium sulphide or to H2S gas inhalation, and levels of available blood sulphide were measured. Levels of dissolved H 2S/HS- were concomitantly measured using an amperometric sensor. Key results: Monobromobimane was found to rapidly and quantitatively derivatize sulphide in saline or whole blood to yield the stable small molecule sulphide dibimane. Extraction and quantification of this bis-bimane derivative were validated via reversed-phase HPLC separation coupled to fluorescence detection, and also by mass spectrometry. Baseline levels of sulphide in blood were in the range of 0.4-0.9 μM. Intravenous administration of sodium sulphide solution (2-20 mg·kg-1·h-1) or inhalation of H2S gas (50-400 ppm) elevated reactive sulphide in blood in a dose-dependent manner. Each 1 mg·kg-1·h -1 of sodium sulphide infusion into rats was found to be pharmacokinetically equivalent to approximately 30 ppm of H2S gas inhalation. Conclusions and implications: The monobromobimane derivatization method is a sensitive and reliable means to measure reactive sulphide species in whole blood. Using this method, we have established a bioequivalence between infused sodium sulphide and inhaled H2S gas.

Original languageEnglish (US)
Pages (from-to)941-957
Number of pages17
JournalBritish Journal of Pharmacology
Volume160
Issue number4
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Sulfides
Pharmacokinetics
Gases
Inhalation
Mass Spectrometry
High Pressure Liquid Chromatography
Hydrogen Sulfide
Therapeutic Equivalency
monobromobimane
Fluorescence Spectrometry
Intravenous Infusions
Intravenous Administration
Cysteine
Fluorescence
sodium sulfide

Keywords

  • Amperometric detection
  • Bimane
  • Blood
  • Fluorescence detection
  • Hydrogen sulphide
  • Monobromobimane
  • Pharmacokinetics
  • Sodium sulphide

ASJC Scopus subject areas

  • Pharmacology
  • Medicine(all)

Cite this

A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood. / Wintner, Edward A.; Deckwerth, Thomas L.; Langston, William; Bengtsson, Asa; Leviten, Dina; Hill, Paul; Insko, Michael A.; Dumpit, Ronald; Vandenekart, Emily; Toombs, Christopher F.; Szabo, Csaba.

In: British Journal of Pharmacology, Vol. 160, No. 4, 2010, p. 941-957.

Research output: Contribution to journalArticle

Wintner, EA, Deckwerth, TL, Langston, W, Bengtsson, A, Leviten, D, Hill, P, Insko, MA, Dumpit, R, Vandenekart, E, Toombs, CF & Szabo, C 2010, 'A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood', British Journal of Pharmacology, vol. 160, no. 4, pp. 941-957. https://doi.org/10.1111/j.1476-5381.2010.00704.x
Wintner, Edward A. ; Deckwerth, Thomas L. ; Langston, William ; Bengtsson, Asa ; Leviten, Dina ; Hill, Paul ; Insko, Michael A. ; Dumpit, Ronald ; Vandenekart, Emily ; Toombs, Christopher F. ; Szabo, Csaba. / A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood. In: British Journal of Pharmacology. 2010 ; Vol. 160, No. 4. pp. 941-957.
@article{74cbf0ce19334407a83a80ed98aad6ea,
title = "A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood",
abstract = "Background and purpose: Hydrogen sulphide (H2S) is a labile, endogenous metabolite of cysteine, with multiple biological roles. The development of sulphide-based therapies for human diseases will benefit from a reliable method of quantifying H2S in blood and tissues. Experimental approach: Concentrations of reactive sulphide in saline and freshly drawn whole blood were quantified by reaction with the thio-specific derivatization agent monobromobimane, followed by reversed-phase fluorescence HPLC and/or mass spectrometry. In pharmacokinetic studies, male rats were exposed either to intravenous infusions of sodium sulphide or to H2S gas inhalation, and levels of available blood sulphide were measured. Levels of dissolved H 2S/HS- were concomitantly measured using an amperometric sensor. Key results: Monobromobimane was found to rapidly and quantitatively derivatize sulphide in saline or whole blood to yield the stable small molecule sulphide dibimane. Extraction and quantification of this bis-bimane derivative were validated via reversed-phase HPLC separation coupled to fluorescence detection, and also by mass spectrometry. Baseline levels of sulphide in blood were in the range of 0.4-0.9 μM. Intravenous administration of sodium sulphide solution (2-20 mg·kg-1·h-1) or inhalation of H2S gas (50-400 ppm) elevated reactive sulphide in blood in a dose-dependent manner. Each 1 mg·kg-1·h -1 of sodium sulphide infusion into rats was found to be pharmacokinetically equivalent to approximately 30 ppm of H2S gas inhalation. Conclusions and implications: The monobromobimane derivatization method is a sensitive and reliable means to measure reactive sulphide species in whole blood. Using this method, we have established a bioequivalence between infused sodium sulphide and inhaled H2S gas.",
keywords = "Amperometric detection, Bimane, Blood, Fluorescence detection, Hydrogen sulphide, Monobromobimane, Pharmacokinetics, Sodium sulphide",
author = "Wintner, {Edward A.} and Deckwerth, {Thomas L.} and William Langston and Asa Bengtsson and Dina Leviten and Paul Hill and Insko, {Michael A.} and Ronald Dumpit and Emily Vandenekart and Toombs, {Christopher F.} and Csaba Szabo",
year = "2010",
doi = "10.1111/j.1476-5381.2010.00704.x",
language = "English (US)",
volume = "160",
pages = "941--957",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood

AU - Wintner, Edward A.

AU - Deckwerth, Thomas L.

AU - Langston, William

AU - Bengtsson, Asa

AU - Leviten, Dina

AU - Hill, Paul

AU - Insko, Michael A.

AU - Dumpit, Ronald

AU - Vandenekart, Emily

AU - Toombs, Christopher F.

AU - Szabo, Csaba

PY - 2010

Y1 - 2010

N2 - Background and purpose: Hydrogen sulphide (H2S) is a labile, endogenous metabolite of cysteine, with multiple biological roles. The development of sulphide-based therapies for human diseases will benefit from a reliable method of quantifying H2S in blood and tissues. Experimental approach: Concentrations of reactive sulphide in saline and freshly drawn whole blood were quantified by reaction with the thio-specific derivatization agent monobromobimane, followed by reversed-phase fluorescence HPLC and/or mass spectrometry. In pharmacokinetic studies, male rats were exposed either to intravenous infusions of sodium sulphide or to H2S gas inhalation, and levels of available blood sulphide were measured. Levels of dissolved H 2S/HS- were concomitantly measured using an amperometric sensor. Key results: Monobromobimane was found to rapidly and quantitatively derivatize sulphide in saline or whole blood to yield the stable small molecule sulphide dibimane. Extraction and quantification of this bis-bimane derivative were validated via reversed-phase HPLC separation coupled to fluorescence detection, and also by mass spectrometry. Baseline levels of sulphide in blood were in the range of 0.4-0.9 μM. Intravenous administration of sodium sulphide solution (2-20 mg·kg-1·h-1) or inhalation of H2S gas (50-400 ppm) elevated reactive sulphide in blood in a dose-dependent manner. Each 1 mg·kg-1·h -1 of sodium sulphide infusion into rats was found to be pharmacokinetically equivalent to approximately 30 ppm of H2S gas inhalation. Conclusions and implications: The monobromobimane derivatization method is a sensitive and reliable means to measure reactive sulphide species in whole blood. Using this method, we have established a bioequivalence between infused sodium sulphide and inhaled H2S gas.

AB - Background and purpose: Hydrogen sulphide (H2S) is a labile, endogenous metabolite of cysteine, with multiple biological roles. The development of sulphide-based therapies for human diseases will benefit from a reliable method of quantifying H2S in blood and tissues. Experimental approach: Concentrations of reactive sulphide in saline and freshly drawn whole blood were quantified by reaction with the thio-specific derivatization agent monobromobimane, followed by reversed-phase fluorescence HPLC and/or mass spectrometry. In pharmacokinetic studies, male rats were exposed either to intravenous infusions of sodium sulphide or to H2S gas inhalation, and levels of available blood sulphide were measured. Levels of dissolved H 2S/HS- were concomitantly measured using an amperometric sensor. Key results: Monobromobimane was found to rapidly and quantitatively derivatize sulphide in saline or whole blood to yield the stable small molecule sulphide dibimane. Extraction and quantification of this bis-bimane derivative were validated via reversed-phase HPLC separation coupled to fluorescence detection, and also by mass spectrometry. Baseline levels of sulphide in blood were in the range of 0.4-0.9 μM. Intravenous administration of sodium sulphide solution (2-20 mg·kg-1·h-1) or inhalation of H2S gas (50-400 ppm) elevated reactive sulphide in blood in a dose-dependent manner. Each 1 mg·kg-1·h -1 of sodium sulphide infusion into rats was found to be pharmacokinetically equivalent to approximately 30 ppm of H2S gas inhalation. Conclusions and implications: The monobromobimane derivatization method is a sensitive and reliable means to measure reactive sulphide species in whole blood. Using this method, we have established a bioequivalence between infused sodium sulphide and inhaled H2S gas.

KW - Amperometric detection

KW - Bimane

KW - Blood

KW - Fluorescence detection

KW - Hydrogen sulphide

KW - Monobromobimane

KW - Pharmacokinetics

KW - Sodium sulphide

UR - http://www.scopus.com/inward/record.url?scp=77952859292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952859292&partnerID=8YFLogxK

U2 - 10.1111/j.1476-5381.2010.00704.x

DO - 10.1111/j.1476-5381.2010.00704.x

M3 - Article

VL - 160

SP - 941

EP - 957

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 4

ER -